Rating Change
HC Wainwright & Co. analysts reiterated a Buy rating on Q32 Bio Inc. (NASDAQ:QTTB) on July 28, 2026.
reiterateNASDAQ:QTTB
HC Wainwright & Co. Reiterates Buy Rating on Q32 Bio Inc. (QTTB)
Rating Change HC Wainwright & Co. analysts reiterated a Buy rating on Q32 Bio Inc. (NASDAQ:QTTB) on July 28, 2026.
Market Context
Q32 Bio Inc. operates in the Healthcare sector. The stock currently trades at $15.54 with a market capitalization of $39.2M.
Analyst coverage from HC Wainwright & Co. provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Q32 Bio Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Q32 Bio Inc.
Among the 10 most recent ratings: 7 Buy, 3 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 28, 2026 | HC Wainwright & Co. | Buy | N/A |
| Jul 13, 2026 | Oppenheimer | Outperform | N/A |
| Jul 13, 2026 | Wells Fargo | Overweight | N/A |
| May 22, 2026 | Mizuho | Outperform | N/A |
| May 18, 2026 | Cantor Fitzgerald | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View QTTB Stock Page
Frequently Asked Questions
What does a Buy rating mean for QTTB?
A Buy rating from HC Wainwright & Co. reflects the analyst's outlook on Q32 Bio Inc. (NASDAQ:QTTB). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the QTTB forecast page.